CAS: 1489389-18-5

CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and CDK1.Cost-effective and quality-assured.

CCT245737

CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The compound induces caspase-independent cell death by activating the death protein. CCT245737 also exhibits chemoresistance and kinase selectivity, which makes it an attractive candidate for the treatment of cancer.